Because EOC cells overexpress NGF/TRKA, which act as proliferative and pro-angiogenic mediators, these results suggest that inhibition of the COX-2/PGE2 axis represents an attractive therapeutic approach to prevent angiogenesis and therefore tumor growth in EOC. Here, PTGS2 is linked to neoplasm.